Prolonged Survival in a Non-Small Cell Lung Cancer with Brain Metastasis Treated with a Brain Mass Evacuation and Gefi tinib

Main Authors: Hardianti, Mardiah Suci, Kurnianda, Johan
Format: Article info application/pdf eJournal
Bahasa: eng
Terbitan: Faculty of Medicine Universitas Gadjah Mada , 2017
Subjects:
Online Access: http://journal.ugm.ac.id/jain/article/view/22393
http://journal.ugm.ac.id/jain/article/view/22393/14942
Daftar Isi:
  • The incidence of brain metastasis (BM) is reported to be increase about 20-40% over the last few years in patients with non-small-cell lung cancer (NSCLC).1 The use of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) in NSCLC patients with BM, especially those harboring EGFR mutations have been reported.